Financial

CORRECTION: 2025’s Top-Rated EHR Vendors Across 40 Medical & Surgical Specialties: Black Book Insights Into Innovation and Client-Centric Excellence

Correction: This release has been updated to reflect accurate specialty-focused EHR top ratings. NextGen Healthcare has achieved five specialty-focused EHR…

11 months ago

ImageTrend Acquires biospatial

LAKEVILLE, Minn., Jan. 6, 2025 /PRNewswire/ -- Today ImageTrend announces the purchase of biospatial, based in Durham, NC for an…

11 months ago

U.S. Ambulatory EHR Market Report 2024-2031 – Integration of AI and ML Technologies to Offer Growth Opportunities for Market Players – ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "U.S. Ambulatory EHR Market Size, Share, Forecast, & Trends Analysis by Deployment Mode, Type Application, Practice, End User…

11 months ago

FDA Proposes Framework to Advance Credibility of AI Models Used for Drug and Biological Product Submissions

SILVER SPRING, Md., Jan. 6, 2025 /PRNewswire/ -- Today, the U.S. Food and Drug Administration issued draft guidance to provide recommendations…

11 months ago

FDA Issues Comprehensive Draft Guidance for Developers of Artificial Intelligence-Enabled Medical Devices

Guidance Shares Strategies to Address Transparency and Bias, while Providing Key Considerations and Recommendations on Product Design, Development and Documentation…

11 months ago

SIPS Healthcare Solutions’ New Multimillion-Dollar Tech Acquisition Brings Affordable AI-Driven Innovation to Safety Net and Community Hospitals Nationwide

DALLAS, Jan. 6, 2025 /PRNewswire/ -- In a landmark move to revolutionize sterile processing and perioperative services, SIPS Healthcare Solutions…

11 months ago

Veterans Benefits Administration awards medical disability examination services contract to Leidos QTC Health Services

RESTON, Va., Jan. 6, 2025 /PRNewswire/ -- Leidos (NYSE:LDOS) today announced that its wholly owned subsidiary, QTC Medical Services, operating under the…

11 months ago

AI/ML Innovations Inc. Announces Appointment of Peter Kendall as President and Chief Commercialization Officer

Accomplished Commercialization Leader to Drive Global Growth.Proven Expertise in Scaling Health Tech Businesses - Mr. Kendall Brings a Track Record…

11 months ago

Tempest Receives Orphan Drug Designation from the U.S. Food and Drug Administration for Amezalpat to Treat Patients with Hepatocellular Carcinoma (HCC)

BRISBANE, Calif., Jan. 06, 2025 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (Nasdaq: TPST), a clinical-stage biotechnology company developing first-in-class1 targeted…

11 months ago

Baracoda Unveils BConnect: The World’s First AI-Powered Platform for Rapid IoT Development

Privacy-by-design, low-code platform helps companies bring AI-driven smart devices and gamified apps to market 5 times faster. LAS VEGAS and…

11 months ago